Furthermore, hs-cTnT concentrations (median, IQR) were significantly higher in mild (4.2 pg/mL, <3.0–7.3), moderate (4.7 pg/mL, <3.0–7.3), and severe CAD (6.5 pg/mL, 3.6–9.4) as compared to patients without CAD (3.3 pg/mL, <3.0–5.3), all P<0.001. This evidence concerns the gene TNNT2 and coronary artery disorder.